eGenesis is a biotechnology company focused on transforming solid organ and therapeutic cell transplantation through advanced genome engineering and gene editing. The company develops human-compatible organs and cells (HuCo™) and pursues xenotransplantation solutions to address the organ shortage, with research and development centered in the Cambridge, Massachusetts area. Its work aims to improve patient outcomes for those in need of transplants by advancing translational therapies and creating new transplantation modalities.
No recent news for this company.
No recent deals for this company.